Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.810 | 0.810 | 0.000 |
Stocks | 99.190 | 99.190 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.059 | 17.782 |
Price to Book | 5.600 | 2.856 |
Price to Sales | 4.647 | 2.026 |
Price to Cash Flow | 19.826 | 11.657 |
Dividend Yield | 1.452 | 2.105 |
5 Years Earnings Growth | 11.581 | 10.947 |
Name | Net % | Category Average |
---|---|---|
Technology | 31.300 | 22.061 |
Healthcare | 19.840 | 14.310 |
Industrials | 14.700 | 12.104 |
Financial Services | 14.480 | 15.464 |
Communication Services | 6.590 | 7.260 |
Basic Materials | 6.120 | 4.379 |
Consumer Defensive | 4.630 | 8.416 |
Utilities | 2.340 | 2.559 |
Number of long holdings: 44
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 8.57 | - | - | |
Alphabet Inc Class A | - | 6.54 | - | - | |
Novo Nordisk B | DK0062498333 | 5.06 | 939.2 | +1.76% | |
ASML Holding | NL0010273215 | 4.85 | 885.40 | +3.66% | |
Taiwan Semiconductor Manufacturing Co Ltd ADR | - | 4.22 | - | - | |
Visa Inc Class A | - | 4.17 | - | - | |
Eli Lilly and Co | - | 4.16 | - | - | |
Intuit Inc | - | 3.42 | - | - | |
Thermo Fisher Scientific Inc | - | 3.24 | - | - | |
Synopsys Inc | - | 3.16 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest USA KL NOK | 1.13B | 15.85 | 17.83 | 15.79 | ||
Danske Invest Horisont 20 NOK | 588.17M | 3.56 | 3.25 | - | ||
Danske Invest Horisont 20 NOK I | 354.3M | 3.63 | 3.46 | - | ||
Danske Invest Horisont 50 NOK | 749.76M | 7.20 | 6.25 | - | ||
Danske Invest Horisont 50 NOK I | 297.46M | 7.25 | 6.42 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review